This is the 22nd and final episode of the MedCity Moves podcast. Moving forward, Senior Reporter Katie Adams will continue to publish a roundup article at the end of each month listing recent ...

Endoscopy, the standard for detecting esophageal precancer, is quite an invasive procedure — so a lot of people who should be ...

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Piraye Yurttas ...

Health systems across the country are scaling hybrid and home-based care models by integrating virtual visits with in-person services, deploying remote monitoring technologies, and partnering with ...

The evolution of customer engagement has reached an inflection point where success is no longer determined by the volume of data collected, but by how effectively organizations can translate that ...

Highly anticipated Phase 2 data for Amgen’s obesity drug show that on average, participants lost about 20% of their weight after one year of treatment, results that put the experimental medicine ...

The Health Resources and Services Administration (HRSA) announced last week a $52 million investment in 54 health centers to improve access to primary care for those preparing to leave incarceration.

Roche, already partnered with Poseida Therapeutics in the development of off-the-shelf cell therapies for blood cancers, is broadening its ambitions with the modality through a deal to acquire the ...

Cortica's $80 million raise was co-led by Morgan Health and Nexus NeuroTech Ventures and included participation from Autism ...

A BridgeBio Pharma drug developed for an increasingly prevalent cardiovascular condition has won FDA approval, marking a comeback for a company and a molecule with a turbulent history. But ...